Brusco, A. et al. Analysis of SCA8 and SCA12 loci in 134 Italian ataxic patients negative for SCA1 3, 6 and 7 CAG expansions.
In this part of the study DNA samples of 67 patients negative for previous candidate gene approaches were sequenced.
This trial enrolled patients negative for all established clinico-molecular risk-factors (termed 'standard-risk (SR)' disease12), a group for which there is an urgent unmet need to develop biomarker-driven treatment strategies.
The Clinical Neuropsychologist, 13, 545 561] criteria for malingered neurocognitive dysfunction were compared to 14 toxic exposure patients negative for evidence of malingering.
In conclusion, the PBC Screen is an appropriate first-line test for the diagnosis of PBC, including for patients negative for markers assessed using conventional methods.
OHB is defined as the presence of HBV DNA in blood or liver tissues in patients negative for HBsAg, with or without any HBV antibodies.
Thirty-three patients who met Slick et al. criteria for Malingered Neurocognitive Dysfunction were compared to 17 toxic exposure patients negative for evidence of malingering, 14 TBI patients and 22 memory disorder patients, both groups without incentive.
In addition, patients negative for nDNA mutations showed different mtDNA backgrounds.
For those MDS/MPD-U patients negative for the V617F mutation, previously undetected lesions were also identified by SNP-A.
Patients negative for both cluster and chills were less likely to be with influenza A infection (NLR 0.51; 95% CI 0.29 0.90).
Finally, 100 patients negative for all influenza strains were randomly selected from the remaining influenza negative ARI patients (presenting between 27 April and 11 June 2009).
